HighTower Advisors’s Biotricity, Inc. Common Stock BTCY Stock Holding History

HighTower Advisors’s Portfolio BTCY Stock Details BTCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-7,870	Closed	-$22K	–	3764
2023 Q1	$22K	Hold	7,870	–	–	﹤0.01%	3141
2022 Q4	$21K	Hold	7,870	–	–	﹤0.01%	3131
2022 Q3	$38K	Hold	7,870	–	–	﹤0.01%	2917
2022 Q2	$84K	Hold	7,870	–	–	﹤0.01%	2828
2022 Q1	$107K	Hold	7,870	–	–	﹤0.01%	2977
2021 Q4	$188K	Sell	7,870 -1,613	-17%	-$38K	﹤0.01%	2798
2021 Q3	$167K	Buy	+9,483	New	+$178K	﹤0.01%	2755

Other funds holding BTCY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SFCL

Strengthening Families & Communities LLC Boston, Massachusetts $450M AUM 41.19% 1-Year Est. Return

AWM

AE Wealth Management Topeka, Kansas $21.5B AUM 26.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

SWMP

Signature Wealth Management Partners Montvale, New Jersey $214M AUM 27.04% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

HighTower Advisors's BTCY Position: Q2 2023 in Review

HighTower Advisors sold out of Biotricity, Inc. Common Stock (BTCY) in Q2 2023, closing a stake of 7,870 shares — an estimated $22K sold.

HighTower Advisors first reported a position in BTCY in Q3 2021 and held it in 7 quarters. The position peaked at $188K in Q4 2021. 23 funds tracked by Wall St. Rank hold BTCY as of Q2 2023.

HighTower Advisors reported no remaining Biotricity, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
HighTower Advisors sold 7,870 Biotricity, Inc. Common Stock shares in Q2 2023, an estimated $22K.
HighTower Advisors first reported a position in Biotricity, Inc. Common Stock in Q3 2021 and held it in 7 quarters.
HighTower Advisors's Biotricity, Inc. Common Stock position peaked at $188K in Q4 2021.
23 funds tracked by Wall St. Rank held Biotricity, Inc. Common Stock as of Q2 2023.

Based on HighTower Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.